Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder

American Journal of Psychiatry

Volumn 159, Issue 2, 2002, Pages 255-262

  Volavka, Jan ^a   Czobor, Pal ^a   Sheitman, Brian ^a   Lindenmayer, Jean Pierre ^a   Citrome, Leslie ^a   McEvoy, Joseph P ^a   Cooper, Thomas B ^a   Chakos, Miranda ^a   Lieberman, Jeffrey A ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CLOZAPINE; DIPHENHYDRAMINE; HALOPERIDOL; LORAZEPAM; OLANZAPINE; RISPERIDONE;

ADULT; AGITATION; AGRANULOCYTOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOIDISM; SCHIZOPHRENIA; SEIZURE; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHRONIC DISEASE; CLOZAPINE; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PIRENZEPINE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0036159250     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.2.255     Document Type: Article

References (27)

1. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
2. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia
3. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia
4. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind study
5. Clozapine and risperidone in chronic schizophrenia: Effects on symptoms, parkinsonian side effects, and neuroendocrine response
6. Clinical and neurocognitive effects of clozapine and risperidone in treatment refractory schizophrenics: A prospective study
7. Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: A retrospective analysis
8. Risperidone in treatment-refractory schizophrenia
9. Newer antipsychotics in treatment-resistant schizophrenia
10. The positive and negative syndrome scale (PANSS) for schizophrenia
11. A prospective study of clozapine in treatment-resistant schizophrenic patients, I: Preliminary report
12. Reliability and validity of the positive and negative syndrome scale for schizophrenics
13. Extrapyramidal symptom rating scale
14. Bayes estimates for the linear model
15. Random regression models: A comprehensive approach to the analysis of longitudinal psychiatric data
16. Treatment of negative symptoms
17. Antipsychotic-induced weight gain and therapeutic response: A differential association
18. Novel antipsychotics: Comparison of weight gain liabilities
19. Risperidone-induced leucopenia and neutropenia
20. Risperidone use at a state hospital: A clinical audit 2 years after the first wave of risperidone prescriptions
21. Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
22. Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: Simultaneous determination by a high performance liquid chromatography with electrochemical detection
23. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine
24. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response